BofA Securities Starts Reneo Pharmaceuticals (RPHM) at Buy; sees 250% upside on blockbuster potential
Tweet Send to a Friend
(Updated - July 3, 2023 7:36 AM EDT)
BofA Securities analyst Jason Zemansky initiates coverage on Reneo Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Jason Zemansky initiates coverage on Reneo Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
